Current Price Status
Stock is Shooting to the Moon
Stock is over-priced on the upper end by the market with the expectation of annual earning growth at 1129.83% to match current price.
Stock in booming mode can be traded very volatile, price can swing largely day-to-day. While having big upside potential, the downside risk can be huge if the stock is not meeting the market expectation.
Company is not in Profit
- BIOHLDG current price is 950% above OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
UnderperformedBIOHLDG past 5-day return lagged behind the Pharmaceuticals industry average return by 1.11%
Below 30-Day AverageCurrent price RM0.21 is below 30-day average RM0.22 by 4.8%
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
Recent Positive Revenue Growth
BIOHLDG managed to achieve better revenue growth for past 2 quarters by average +75%.
Continued Losing Money
BIOHLDG has been losing money in the 4 of the past 5 quarters.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Increasing
Surge in trading volume tends to bring more price volatility in near term.
BIOHLDG recent daily traded volume is 59.26% higher than past month average.
|Past 30-Day||Past 5-Day|
|54k daily||86k daily|
Price History Chart
Past 30-day Average Price: RM0.22
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stocks that has more than two consecutive money-losing quarters
Stock Thematic Baskets
Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.
Market News & Investor Opinions
Stock Company Profile
BIOALPHA HOLDINGS BERHAD
Bioalpha Holdings Bhd. operates as an investment holding company. The firm engages in the manufacture and sale of health supplement products. It operates through the following segments: Trading and Manufacturing, Retails Pharmacy and Others. The Trading and Manufacturing segment refers to the research, development, manufacture, importer, exporters, distribution and trader of nutritional and healthcare products. The Retails Pharmacy segment includes the pharmacist, druggist and chemicals. The Others segment comprises the investment holding and provision of management. The company was founded by Tian Kok Hon on June 21, 2011 and is headquartered in Kajang, Malaysia.